Physician profile
Abhishek Chatterjee
NPI 1760578579
$658,891.19
in general payments reported to CMS, 2019-2025
56 companies · $262K in 2025
The $262K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $15K · 2021: $36K · 2022: $67K · 2023: $137K · 2024: $91K · 2025: $262K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $314K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $89K · Travel and Lodging: $49K · Food and Beverage: $28K · Education: $7,150 · Honoraria: $2,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $314,397.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $89,168.25 |
| Travel and Lodging | $48,735.03 |
| Food and Beverage | $28,027.83 |
| Education | $7,150.00 |
| Honoraria | $2,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $200,364.70 | 2019-2023 | Prevena, V.A.C. Veraflo, Prevena Restor Bellaform |
| Dilon Technologies, INC. | $136,836.11 | 2022-2025 | Hemoblast Bellows |
| Stryker Corporation | $124,148.22 | 2024-2025 | Molli, Spy-Phi System, 1788 |
| Solventum Corporation | $108,177.37 | 2024-2025 | Prevena, V.A.C. Veraflo, Prevena Restor Bellaform |
| Molnlycke Health Care US, LLC | $37,699.88 | 2019-2025 | Biogel Pi Micro, Biogel Indicator System, Biogel Pi Indicator Underglove |
| Biom'Up France Sas | $18,525.14 | 2020-2021 | |
| Hologic INC | $7,200.00 | 2023-2024 | Trident Specimen Radiography System |
| Deroyal Industries, INC. | $4,125.74 | 2022-2023 | Prospera Pro Negative Pressure Wound Therapy Units |
| Aroa Biosurgery Incorporated | $3,723.62 | 2023-2025 | |
| Rti Surgical, INC | $2,400.00 | 2025 | |
| Pfizer INC. | $2,175.37 | 2019-2025 | |
| Mentor Worldwide LLC | $1,985.72 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Biom'Up Sa | $1,182.45 | 2019 | |
| W. L. Gore & Associates, INC. | $845.32 | 2019-2024 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Axogen | $819.29 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molli Surgical (US) INC | $787.56 | 2024 | |
| Kerecis Limited | $750.55 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $669.01 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Sientra, INC. | $576.48 | 2021-2022 | |
| Abbvie INC. | $474.50 | 2023-2025 | Alloderm |
| Tela Bio, INC. | $427.73 | 2020-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Guard Medical INC. | $426.41 | 2022 | |
| Genentech USA, INC. | $344.63 | 2019-2020 | |
| Smith+Nephew, INC. | $343.59 | 2019-2023 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Ethicon US, LLC | $342.63 | 2019-2025 | Ethicon, Vistaseal |
| Endomagnetics Ltd | $320.08 | 2021-2023 | Magseed, Magtrace |
| Musculoskeletal Transplant Foundation INC. | $265.58 | 2022-2023 | |
| Organogenesis INC. | $247.86 | 2022-2023 | Puraply |
| Avita Medical Americas, LLC | $229.76 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Polarityte, INC. | $210.57 | 2019-2020 | |
| Elucent Medical | $201.50 | 2023 | |
| Innovation Technologies INC | $186.21 | 2022-2024 | Irrisept |
| Medtronic USA, INC. | $167.85 | 2020 | |
| Focal Therapeutics, INC. | $165.07 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $160.73 | 2019 | |
| Allergan, INC. | $135.77 | 2019 | |
| Merit Medical Systems INC | $127.56 | 2021 | |
| Puma Biotechnology, INC. | $117.32 | 2019-2020 | |
| Tei Biosciences INC | $114.07 | 2019 | |
| Biocomposites INC | $112.48 | 2022 | |
| Clearpoint Neuro, INC. | $109.48 | 2024 | Clearpoint |
| Clozex Medical INC | $92.48 | 2023 | Clozex Skin Closure Device |
| Polynovo North America LLC | $79.11 | 2023-2025 | Novosorb Btm |
| Covidien Lp | $69.51 | 2019 | |
| Seagen INC. | $66.55 | 2019-2020 | |
| Acera Surgical, INC. | $55.12 | 2024-2025 | Restrata Wound Matrix |
| Merck Sharp & Dohme LLC | $47.74 | 2023-2025 | Keytruda |
| Eisai INC. | $47.11 | 2019 | |
| Zimmer Biomet Holdings, INC. | $44.09 | 2019 | |
| Csl Behring | $35.01 | 2024 | Haegarda |
| Takeda Pharmaceuticals U.S.A., INC. | $34.97 | 2022 | |
| Medtronic, INC. | $29.13 | 2022 | |
| Amgen INC. | $22.79 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.38 | 2019 | |
| Convatec INC. | $13.63 | 2025 | |
| Misonix INC | $12.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhishek Chatterjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.